JOIN DAKTARI BIOTECHNOLOGY LTD.

BECOME A MEDICINES AND VACCINES PRODUCER

Daktari Biotechnology Ltd is inviting FOUNDER ANGEL INVESTORS to join in advancing the progress of medicines and vaccines in Kenya. The Founder Angel Investors will take up 3 million shares of Ksh 500 (About $4). The minimum angel investment is 100 shares of Ksh 50,000 (About $400).

WHY BECOME A DAKTARI BIOTECHNOLOGY FOUNDER ANGEL INVESTOR?

One of the reasons Kenya's and Africa's life expectancy is below 70 years is the lack of medicines and vaccines.

Africa's population of 1.4 billion is expected to grow and reach 2 billion. This is a huge market for medicine and vaccines. Daktari Biotechnology Ltd.'s goal is to produce medicines and vaccines for this African population.

As the world GDP grew to $106 trillion (2024), the medicine and vaccines revenue grew to about $2 trillion. The world’s 50 largest pharmaceutical companies received about $1 trillion of this revenue. Their market valuation is $4.7 trillion. (Read)

Daktari Biotechnology Ltd will be part of growing Africa's GDP from its current $3 trillion to $20 trillion by 2075. The African medicines and vaccines market will grow to about $400 billion.

Daktari Biotechnology Ltd's goal is to achieve a revenue of 5% of the $400 billion African market (about $20 billion, KES 2 trillion). Upon achieving this, the Daktari Biotechnology shares could reach a value of $40 billion. The 3 million shares taken by Founder Angel Investors could have a value of $3 billion, about Ksh 300 billion. This is a growth from Ksh 500 to Ksh 100,000 in 50 years.

HOW TO INVEST?

FILL IN THE INVESTMENT FORM BELOW

KES


CALL TO INVEST: 5th May 2025 TO 30th May 2025

Call / WhatsApp:
Dr. Wilson Endege: +1 (781) 492-6851 (Founder, Daktari Biotechnology)
Daktari Biotechnology: +254 113 217 148 (Voi Office)

COMPANY PLAN AT DIASPORA UNIVERSITY TOWN

Daktari Biotechnology Ltd is located at Diaspora University Town, where it is building the Medicine and Vaccine plant at an 11 acre plot.

The company will also build 3 properties for its pharmaceutical business line. The company will open 8 Pharmacies in Diaspora University Town.

As Diaspora University Town GDP reaches Ksh 15 billion, a medicine and vaccine market of Ksh 300 million will be created.

MEDICINE AND VACCINE DESIGN

Architect Prof. David Ogoli is the designer of the plot and medicine and vaccine building. 80% of the investment by angel investors will fund the plant building and equipment installed.

DIASPORA UNIVERSITY AFFILIATION

The Scientists founding Daktari Biotechnology Ltd are also part of the founding team of the Diaspora University departments for teaching and research.

DEVELOPMENT PLANS, TIMELINE, & INVESTMENT APPLICATION

PLAN TIMELINE AND KSH 1.5 BILLION APPLICATION
Plant Construction & Equipment Installation 12 to 15 months following the investment: construct and equip the plant.
Ksh 1 billion
Human & Animal Medicines & Vaccines Research & Manufacturing Progress research on diverse products in U.S. labs and transfer research once the building is completed.
Start pre-clinical trials for ready products.
Produce and package medicine and vaccines as approvals are given.
Ksh 400 million
DKTB Pharmacies & Products Market Open the first pharmacy in Voi.
Open 8 pharmacies at DUT.
Sell medicines and vaccines to the DUT market; market planned to grow to Ksh 400 million as Ksh 20 billion in new GDP is achieved.
100 pharmacies to be established in the next 7 years across all 47 counties.
Ksh 100 million
Diaspora University Departments Start the Biology & Biotechnology Department.
Start the Chemistry & Biochemistry Department.
Progress research through the departments.
Educate future workers for the company.
Diaspora University Medical Hospital Collaborate with the University Hospital on research.
Sell medicines and vaccines to the hospital.

DAKTARI BIOTECH 5-YEAR PLAN

JOBS, PHARMACIES, PRODUCT PRODUCTION, REVENUE, EXPENSES, PROFITS & DIVIDENDS

Year 1 Year 2 Year 3 Year 4 Year 5
Jobs 20 100 200 400 1,000
Pharmacies 3 10 30 60 100
Product Prod - - 1,000,000 10,000,000 100,000,000
Revenue (KES) 50,000,000 100,000,000 1,000,000,000 4,000,000,000 20,000,000,000
Expenses 30,000,000 60,000,000 600,000,000 2,400,000,000 12,000,000,000
Gross Profit 20,000,000 40,000,000 400,000,000 1,600,000,000 8,000,000,000
Tax 6,000,000 12,000,000 120,000,000 480,000,000 2,400,000,000
Net Profit 14,000,000 28,000,000 280,000,000 1,120,000,000 5,600,000,000
Retained 14,000,000 28,000,000 180,000,000 620,000,000 3,600,000,000
Dividend 0 0 100,000,000 500,000,000 2,000,000,000
Dividend/Share - - 10 50 200

REVENUE BASED ON GDP GROWTH

Kenya GDP will grow to about Ksh 25 trillion by 2030.

Diaspora University Town (DUT) GDP growth system of job creation and property development and other economic systems will grow Kenya GDP.

The growth of GDP to Ksh 25 trillion will increase the market for medicines and vaccines in Kenya to about Ksh 500 billion.

Daktari Biotechnology Ltd's plan is set up to achieve sales of at least 5% of the growing market.